Atorvastatin/Aspirin

阿托伐他汀/阿司匹林

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAtorvastatin/Aspirin
Drug Alias Name阿托伐他汀/乙酰水杨酸Aspirin+Atorvastatin乙酰水杨酸/阿托伐他汀Aspirin/Atorvastatin阿托伐他汀+阿司匹林 +[11
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsHMG-CoA reductase inhibitors
TargetsHMG-CoA reductaseCyclooxygenases
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A